Fluditek syrup 2% fl. 125ml for children

Dosage form

syrup for children

Structure

Carbocisteine, 0 g

Excipients:

Glycerol 5.0 g, Methyl parahydroxybenzoate - 0.15 g, Sucrose - 70.0 g, Sunset yellow dye (E 110) - 0.001 g, Sodium hydroxide - up to pH 6.2, Banana flavor - 0.2 g, Water purified - up to 100 ml.

pharmachologic effect

Mucolytic and expectorant action is due to the activation of sialic transferase - an enzyme of the goblet cells of the bronchial mucosa.

Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretion, restores the viscosity and elasticity of mucus, facilitates its discharge.

Promotes regeneration of the mucous membrane, normalizes its structure, reduces mucus production, activates the activity of the ciliated epithelium, improves mucociliary clearance.

Restores the secretion of immunologically active IgA (specific protection) and the amount of sulfhydryl groups of mucus components (non-specific protection).

Pharmacokinetics

The maximum concentration in blood serum and in the mucous membrane of the respiratory tract is reached 2-3 hours after ingestion and remains in the mucous membrane for 8 hours. It is excreted mainly by the kidneys, partly unchanged, partly in the form of metabolites.

Side effects

Nausea, vomiting, diarrhea, epigastric pain, flatulence, gastrointestinal bleeding, dizziness, weakness, malaise, in rare cases - allergic reactions (itching, urticaria, exanthema, angioedema).

If any of the side effects indicated in the instructions are aggravated, or you notice any other side effects not listed in the instructions, inform your doctor.

Selling features

Available without a prescription

Special conditions

For patients with diabetes mellitus, take into account that the sucrose content per 5 ml (one teaspoon of syrup) is 3.5 g.

Indications

Acute and chronic bronchopulmonary diseases (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis) and inflammatory diseases of the nasal cavity, nasopharynx, paranasal sinuses and middle ear (rhinitis, adenoiditis, sinusitis, otitis media) accompanied by the formation of a viscous secretion (difficult to separate , mucus)

preparation for bronchoscopy and / or bronchography.

Contraindications

Hypersensitivity to carbocisteine ​​or other components of the drug

peptic ulcer of the stomach and duodenum in the acute stage

Chronic glomerulonephritis (in the acute phase), cystitis

· Children under 2 years old.

Caution should be exercised when taking the drug for chronic glomerulonephritis (in history), gastric ulcer and duodenal ulcer (in history).

Drug interactions

When used together with glucocorticosteroids, a synergistic effect is noted.

Increases the effectiveness of antibacterial therapy for inflammatory diseases of the upper and lower respiratory tract.

Enhances the bronchodilator effect of theophylline.

The activity of carbocisteine ​​is weakened by antitussives and atropine-like drugs.

Dosage

For oral administration.

Before using the drug, you should consult your doctor.

5 ml of syrup (1 teaspoon) contains 100 mg of carbocisteine.

Children aged 2 to 5:

5 ml, 2 times a day.

The dosage should not exceed 200 mg / day.

Children over 5 years old:

5 ml, 3 times a day.

The dosage should not exceed 300 mg / day.

Treatment should not continue for more than 8-10 days without consulting a doctor.

Overdose

Symptoms: gastralgia, nausea, diarrhea.

Treatment: symptomatic therapy is performed.

Name ENG

FLUDITEC

Clinical and pharmacological group

Mucolytic drug

ATX code

Carbocisteine

Dosage

20mg / ml x 125ml

Structure

Carbocisteine, 0 g.

Excipients: Glycerol 5.0 g, Methyl parahydroxybenzoate - 0.15 g, Sucrose - 70.0 g, Sunset yellow dye (E 110) - 0.001 g, Sodium hydroxide - up to pH 6.2, Banana flavor - 0.2 g, Purified water - up to 100 ml.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

INN / Active ingredient

carbocisteine

Specifications

Category

Cough

Scope of the drug

Ear, Throat, Nose

Release form

Syrup

Manufacturer country

France

Package quantity, pcs

one

Minimum age from

2 years old

Way of introduction

Through the mouth

Mode of application

For oral administration.

Vacation conditions

Without recipe

Volume, ml.

25 ml

Brand name

Innotech International

Components

measuring glass

The amount of the dosage form in the primary package

125 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Expectorant mucolytic agent

Anatomical and therapeutic characteristics

R05CB03 Carbocisteine

Dosage form

Syrup [for children]

Expiration date in days

730

The target audience

Children

Dosage (volume) of the substance in the preparation

100 ml of syrup contains 2 g carbocisteine

Package weight, g

150